UCLA Vine Street Clinic

ACTTION Phenotyping Substance Use Disorder
Inflammation in Methamphetamine and STIs (aka IMSTI)
Expression of stress markers in MSM living with HIV receiving contingency management for methamphetamine use disorder (a.k.a. “EXPRESS+”)
Randomized, Placebo-Controlled Trial of Injectable Naltrexone and Monthly Injectable Buprenorphine for Cocaine Use Disorder (CURB-2)
MSM and Substances Cohort at UCLA Linking Infections Noting Effects, better known as the M Study


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.